Searched for
NUTRACEUTICAL MARKET INDIA
Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Bain Capital in advanced talks for 25% stake in IndusInd Insurance, marking its first India insurance betBain Capital is nearing a deal to buy a significant stake in IndusInd General Insurance. This acquisition could value the insurer at over s...
- Bain Capital acquires Vitabiotics: UK nutraceutical giant with India’s Meyer Organics valued at $850-900 millionPrivate equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...
- Bain Capital to accquire UK's leading vitamin company VitabioticsPrivate equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...
- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
- LetterOne taps Rahul Mukim to spearhead $2 billion India pushLuxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...
- FSSAI crackdown serves food for thought as packaged food makers seek clearer rulesIn a bid to strengthen consumer protection, India's food regulatory body is intensifying efforts against packaged food companies. The lack ...
- Ethanol ecosystem: Judging fear by noise is not evidence; 15 stocks from the ecosystemSugar is one of the oldest distressed sectors in India. For decades it has swung between glut and shortage, carried heavy debt, was depende...
- Government starts industry consultations on next phase of food processing PLIThe government is planning an expanded Production-Linked Incentive Scheme for the food processing sector. Consultations were held with indu...
- Raising the bar: Saying it with chocolates, from pastries to perfumeChocolate is a versatile ingredient celebrated for its intricate taste and diverse forms. It's integrated into an array of products, from b...
- India's wellness industry poised for growth amid focus on preventive healthcare, rising income: EBG Group chiefIndia's wellness market, valued at over $150 billion, is set for growth fueled by rising health consciousness and disposable incomes. EBG G...
- India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
- India's growth story, not AI trade reversal, will drive foreign flows: Sameer DalalIndia's economic strength, not AI's decline, will drive foreign capital inflows, according to Sameer Dalal. He believes AI's market correct...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
Load More
